Fluralaner 5.46% (w/w) flavored chewable tablet (Bravecto® 1-Month) is effective for treatment of canine generalized demodicosis

Table 3 Assessment of hair regrowth on dogs before and after treatment for generalized demodicosis

Day of study	Score	Body areas with hair regrowth versus pre-administration assessment	Fluralaner tablets	Topical imidacloprid-moxidectin
	Assessment prior to any study treatments
−2	1	Alopecia > 0 to 50% of the body	7/8 (87.5%)	7/8 (87.5%)
	2	Alopecia > 50 to ≤ 90% of the body	1/8 (12.5%)	1/8 (12.5%)
	3	Alopecia > 90% of the body	0/8 (0.0%)	0/8 (0.0%)
	Hair regrowth after treatment on days 0, 28, and 56^a and on day 84
28	1	> 0 to 50% hair regrowth	2/8 (25.0%)	5/8 (62.5%)
	2	> 50 to ≤ 90% hair regrowth	4/8 (50.0%)	3/8 (37.5%)
	3	> 90% improvement	2/8 (25.0%)	0/8 (0.0%)
56	1	> 0 to 50%	0/7 (0.0%)	4/8 (50.0%)
	2	> 50 to ≤ 90%	2/7 (28.6%)	2/8 (25.0%)
	3	> 90%	5/7 (71.4%)	2/8 (25.0%)
84	1	> 0 to 50%	0/7 (0.0%)	1/8 (12.5%)
	2	> 50 to ≤ 90%	0/7 (0.0%)	2/8 (25.0%)
	3	> 90%	7/7 (100.0%)	5/8 (62.5%)

^aHair regrowth assessments were made before treatments were administered on days 28 and 56

ISSN: 1756-3305